Literature DB >> 21494253

Rapid mobilization of hematopoietic progenitors by AMD3100 and catecholamines is mediated by CXCR4-dependent SDF-1 release from bone marrow stromal cells.

Ayelet Dar1, Amir Schajnovitz1, Kfir Lapid1, Alexander Kalinkovich1, Tomer Itkin1, Aya Ludin1, Wei-Ming Kao2, Michela Battista2, Melania Tesio1, Orit Kollet1, Neta Netzer Cohen1, Raanan Margalit1, Eike C Buss1, Francoise Baleux3, Shinya Oishi4, Nobutaka Fujii4, Andre Larochelle5, Cynthia E Dunbar5, Hal E Broxmeyer6, Paul S Frenette2, Tsvee Lapidot1.   

Abstract

Steady-state egress of hematopoietic progenitor cells can be rapidly amplified by mobilizing agents such as AMD3100, the mechanism, however, is poorly understood. We report that AMD3100 increased the homeostatic release of the chemokine stromal cell derived factor-1 (SDF-1) to the circulation in mice and non-human primates. Neutralizing antibodies against CXCR4 or SDF-1 inhibited both steady state and AMD3100-induced SDF-1 release and reduced egress of murine progenitor cells over mature leukocytes. Intra-bone injection of biotinylated SDF-1 also enhanced release of this chemokine and murine progenitor cell mobilization. AMD3100 directly induced SDF-1 release from CXCR4(+) human bone marrow osteoblasts and endothelial cells and activated uPA in a CXCR4/JNK-dependent manner. Additionally, ROS inhibition reduced AMD3100-induced SDF-1 release, activation of circulating uPA and mobilization of progenitor cells. Norepinephrine treatment, mimicking acute stress, rapidly increased SDF-1 release and progenitor cell mobilization, whereas β2-adrenergic antagonist inhibited both steady state and AMD3100-induced SDF-1 release and progenitor cell mobilization in mice. In conclusion, this study reveals that SDF-1 release from bone marrow stromal cells to the circulation emerges as a pivotal mechanism essential for steady-state egress and rapid mobilization of hematopoietic progenitor cells, but not mature leukocytes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21494253      PMCID: PMC4175714          DOI: 10.1038/leu.2011.62

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  62 in total

1.  Physiological migration of hematopoietic stem and progenitor cells.

Authors:  D E Wright; A J Wagers; A P Gulati; F L Johnson; I L Weissman
Journal:  Science       Date:  2001-11-30       Impact factor: 47.728

Review 2.  Innate immunity as orchestrator of stem cell mobilization.

Authors:  M Z Ratajczak; C H Kim; W Wojakowski; A Janowska-Wieczorek; M Kucia; J Ratajczak
Journal:  Leukemia       Date:  2010-08-12       Impact factor: 11.528

3.  Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow.

Authors:  Yoshio Katayama; Michela Battista; Wei-Ming Kao; Andrés Hidalgo; Anna J Peired; Steven A Thomas; Paul S Frenette
Journal:  Cell       Date:  2006-01-27       Impact factor: 41.582

Review 4.  Stem-cell ecology and stem cells in motion.

Authors:  Thalia Papayannopoulou; David T Scadden
Journal:  Blood       Date:  2008-04-15       Impact factor: 22.113

5.  AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor.

Authors:  G A Donzella; D Schols; S W Lin; J A Esté; K A Nagashima; P J Maddon; G P Allaway; T P Sakmar; G Henson; E De Clercq; J P Moore
Journal:  Nat Med       Date:  1998-01       Impact factor: 53.440

Review 6.  The brain-bone-blood triad: traffic lights for stem-cell homing and mobilization.

Authors:  Tsvee Lapidot; Orit Kollet
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2010

Review 7.  uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view.

Authors:  Bernd R Binder; Judit Mihaly; Gerald W Prager
Journal:  Thromb Haemost       Date:  2007-03       Impact factor: 5.249

8.  Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization.

Authors:  Carmine Selleri; Nunzia Montuori; Patrizia Ricci; Valeria Visconte; Maria Vincenza Carriero; Nicolai Sidenius; Bianca Serio; Francesco Blasi; Bruno Rotoli; Guido Rossi; Pia Ragno
Journal:  Blood       Date:  2004-10-19       Impact factor: 22.113

9.  Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4.

Authors:  Sigrid Hatse; Katrien Princen; Gary Bridger; Erik De Clercq; Dominique Schols
Journal:  FEBS Lett       Date:  2002-09-11       Impact factor: 4.124

Review 10.  Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells.

Authors:  Tsvee Lapidot; Isabelle Petit
Journal:  Exp Hematol       Date:  2002-09       Impact factor: 3.084

View more
  99 in total

1.  A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia.

Authors:  Geoffrey L Uy; Michael P Rettig; Ibraheem H Motabi; Kyle McFarland; Kathryn M Trinkaus; Lindsay M Hladnik; Shashikant Kulkarni; Camille N Abboud; Amanda F Cashen; Keith E Stockerl-Goldstein; Ravi Vij; Peter Westervelt; John F DiPersio
Journal:  Blood       Date:  2012-02-02       Impact factor: 22.113

Review 2.  Sympathetic nervous system regulation of the tumour microenvironment.

Authors:  Steven W Cole; Archana S Nagaraja; Susan K Lutgendorf; Paige A Green; Anil K Sood
Journal:  Nat Rev Cancer       Date:  2015-09       Impact factor: 60.716

3.  S1P promotes murine progenitor cell egress and mobilization via S1P1-mediated ROS signaling and SDF-1 release.

Authors:  Karin Golan; Yaron Vagima; Aya Ludin; Tomer Itkin; Shiri Cohen-Gur; Alexander Kalinkovich; Orit Kollet; Chihwa Kim; Amir Schajnovitz; Yossi Ovadya; Kfir Lapid; Shoham Shivtiel; Andrew J Morris; Mariusz Z Ratajczak; Tsvee Lapidot
Journal:  Blood       Date:  2012-01-25       Impact factor: 22.113

4.  The nucleotide sugar UDP-glucose mobilizes long-term repopulating primitive hematopoietic cells.

Authors:  Sungho Kook; Joonseok Cho; Sean Bong Lee; Byeong-Chel Lee
Journal:  J Clin Invest       Date:  2013-07-25       Impact factor: 14.808

5.  A non-myeloablative conditioning approach for long-term engraftment of human and mouse hematopoietic stem cells.

Authors:  Wei Du; Wei Liu; Benjamin Mizukawa; Xun Shang; Jared Sipple; Mark Wunderlich; Hartmut Geiger; Stella Davies; James Mulloy; Qishen Pang; Yi Zheng
Journal:  Leukemia       Date:  2018-06-29       Impact factor: 11.528

6.  Early Repeated Administration of CXCR4 Antagonist AMD3100 Dose-Dependently Improves Neuropathic Pain in Rats After L5 Spinal Nerve Ligation.

Authors:  Fang Xie; Yun Wang; Xueyang Li; Yu-Chieh Chao; Yun Yue
Journal:  Neurochem Res       Date:  2016-05-11       Impact factor: 3.996

Review 7.  Physiology and pharmacology of plerixafor.

Authors:  Simon P Fricker
Journal:  Transfus Med Hemother       Date:  2013-07-19       Impact factor: 3.747

Review 8.  A novel perspective on stem cell homing and mobilization: review on bioactive lipids as potent chemoattractants and cationic peptides as underappreciated modulators of responsiveness to SDF-1 gradients.

Authors:  M Z Ratajczak; C H Kim; A Abdel-Latif; G Schneider; M Kucia; A J Morris; M J Laughlin; J Ratajczak
Journal:  Leukemia       Date:  2011-09-02       Impact factor: 11.528

9.  SDF-1 inhibition targets the bone marrow niche for cancer therapy.

Authors:  Aldo M Roccaro; Antonio Sacco; Werner G Purschke; Michele Moschetta; Klaus Buchner; Christian Maasch; Dirk Zboralski; Stefan Zöllner; Stefan Vonhoff; Yuji Mishima; Patricia Maiso; Michaela R Reagan; Silvia Lonardi; Marco Ungari; Fabio Facchetti; Dirk Eulberg; Anna Kruschinski; Axel Vater; Giuseppe Rossi; Sven Klussmann; Irene M Ghobrial
Journal:  Cell Rep       Date:  2014-09-25       Impact factor: 9.423

10.  Rapid immune reconstitution of SCID-X1 canines after G-CSF/AMD3100 mobilization and in vivo gene therapy.

Authors:  Olivier Humbert; Frieda Chan; Yogendra S Rajawat; Troy R Torgerson; Christopher R Burtner; Nicholas W Hubbard; Daniel Humphrys; Zachary K Norgaard; Patricia O'Donnell; Jennifer E Adair; Grant D Trobridge; Andrew M Scharenberg; Peter J Felsburg; David J Rawlings; Hans-Peter Kiem
Journal:  Blood Adv       Date:  2018-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.